The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.
High Grade Endometrial Stromal Sarcoma (HGESS)

Comments
-
jcotton, I am sorry, I cannot
jcotton, I am sorry, I cannot answer the question you posed simply because I have no experience with either. I think there are a few women here who have experienced Doxil and you might find some information by doing a search of the content and hopefully those ladies chime in.
Please let us know how it goes.
-
HGESS
Treatment of uterine high-grade endometrial stromal sarcoma with apatinib combined with chemotherapy: A case report.
Abstract
RATIONALE: The standard treatment for uterine high-grade endometrial stromal sarcoma (HGESS) is chemotherapy after surgery. However, the traditional combination chemotherapy has certain limitation, for example, the cancer cells will quickly become resistant to the chemotherapy drugs. Apatinib is a small-molecule antiangiogenic agent which has shown promising therapeutic effect against diverse tumor, but it still remains unknown whether apatinib has an antitumor effect in patients with endometrial stromal sarcoma (ESS). Here, we report a case of pulmonary metastasis from uterine HGESS successfully treated with apatinib combined with chemotherapy. We also review relevant literature discussing treatment of ESS.
PATIENTS CONCERNS: A 54-years-old Chinese woman complained of intermittent pain in the waist and abdomen for 4 months. The patient was diagnosed as uterine fibroids before operation. The surgeon performed a total hysterectomy with bilateral salpingo-oophorectomy, resection of peritoneal disseminated lesions, and the pathological examination revealed a HGESS.
DIAGNOSIS: Uterine HGESS stage IV with lung metastases.
INTERVENTIONS: The patient underwent surgery, chemotherapy, chemotherapy combined with apatinib, apatinib maintenance therapy, and radioactive particle implantation for lung metastasis.
OUTCOMES: The patient experienced the above interventions and achieved good results. And continue oral apatinib (500 mg daily) as maintenance therapy. It has been 16 months since the initial diagnosis, and the patient is still in follow-up.
LESSONS: Apatinib combined with chemotherapy and apatinib monotherapy as maintenance therapy could be a new therapeutic strategy for ESS.
PMID
30921232 [Indexed for MEDLINE]PMCID
PMC6455907Full text
-
-
Doxorubicin
I have a different type of cancer (uterine carcinosarcoma or MMMT). My front line treatment consisted of four different chemo drugs. The first four cycles were Paclitaxel/Carboplatin, followed by four cycles of Ifosfamide/Adriamycin.
The Adriamycin that I had is the older from of Doxorubicin, versus the newer Doxil. I did have worse side effects with Ifosfamide/Adriamycin, but I can't say which of the two (or both) caused the problems. However, I have not suffered any long-term effects from chemo, except for some mild neuropathy in my toes (which I attribute to the Paclitaxel/Carboplatin) and most recently some lymphadema in my legs.
I was staged as 3B and am still NED after the chemo and external radiation.
There is a Yahoo group for women with MMMT, which I've referenced in other posts, but I'm sorry that I'm not familiar with one that is specific to HGESS.
Discussion Boards
- All Discussion Boards
- 6 Cancer Survivors Network Information
- 6 Welcome to CSN
- 122.5K Cancer specific
- 2.8K Anal Cancer
- 456 Bladder Cancer
- 312 Bone Cancers
- 1.7K Brain Cancer
- 28.6K Breast Cancer
- 408 Childhood Cancers
- 28K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13.1K Head and Neck Cancer
- 6.4K Kidney Cancer
- 681 Leukemia
- 803 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 242 Multiple Myeloma
- 7.2K Ovarian Cancer
- 69 Pancreatic Cancer
- 493 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 743 Skin Cancer
- 659 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.4K Lifestyle Discussion Boards